Effectiveness And Safety Of Pyrotinib, And Association Of Biomarker With Progression-Free Survival In Patients With Her2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis (Vol 10, 811, 2020)Qitong Chen,Dengjie Ouyang,Munawar Anwar,Ning Xie,Shouman Wang,Peizhi Fan,Liyuan Qian,Gannong Chen,Enxiang Zhou,Lei Guo,Xiaowen Gu,Boni Ding,Xiaohong Yang,Liping Liu,Chao Deng,Zhi Xiao,Jing Li,Yunqi Wang,Shan Zeng,Jinhui Hu,Wei Zhou,Bo Qiu,Zhongming Wang,Jie Weng,Mingwen Liu,Yi Li,Tiegang Tang,Jianguo Wang,Hui Zhang,Bin Dai,Wuping Tang,Tao Wu,Maoliang Xiao,Xiantao Li,Hailong Liu,Lai Li,Wenjun Yi,Quchang OuyangFRONTIERS IN ONCOLOGY（2021）引用 30|浏览11暂无评分关键词breast cancer, HER2, pyrotinib, tumor mutation burden, metastasesAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
